Enumeral Biomedical Corp. — Form D

Enumeral Biomedical Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-09. The offering totals $3.0M, of which $2.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
John J. RydzewskiDirectorNew York, NY
Michael B. WeissDirectorNew York, NY
Daniel B. WolfeDirectorSalem, NH
Derek B. BrandExecutive OfficerNew York, NY
John J. RydzewskiExecutive OfficerNew York, NY
Michael J WeissDirectorNewark, NJ
Daniel B WolfeDirectorMontclair, NJ
John J RydzewskiDirectorCambridge, MA
John J RydzewskiExecutive OfficerCambridge, MA
Arthur H TinkelenbergDirectorCambridge, MA
Arthur H TinkelenbergExecutive OfficerCambridge, MA
Allan B RothsteinDirectorCambridge, MA
Emanuele H OstuniDirectorNew York, NY
Michael H WeissDirectorNew York, NY
Allan H RothsteinDirectorNew York, NY
Barry H BucklandDirectorNew York, NY
Derek H BrandExecutive OfficerNew York, NY
John H RydzewskiDirectorNew York, NY
John H RydzewskiExecutive OfficerNew York, NY
Daniel H WolfeDirectorNew York, NY
Derek B BrandExecutive OfficerNew York, NY
Michael B WeissDirectorNew York, NY
Daniel WolfeDirectorNew York, NY
Emanuele OstuniDirectorNew York, NY
John RydzewskiDirectorNew York, NY

Other filings by this issuer (4)

FiledFormOfferingSold
2014-05-07D$2.0M
2014-02-10D$750K$635K
2013-05-14D$1.5M
2011-04-29D$3.3M$2.0M

More